We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Bedside Monitor Analyses Blood Gases and Glucose

By HospiMedica International staff writers
Posted on 10 Jan 2017
An updated sensor monitors blood gases and blood glucose frequently and directly, enabling earlier interventions and closer patient management.

The next-generation Sphere Medical (Cambridge, United Kingdom) Proxima system includes an in-line disposable sensor that contains an array of electrochemical biosensors on a silicon chip, and a medical grade tablet device with an intuitive touch screen user interface. More...
The system is used for monitoring blood gases and electrolyte levels (including pH, pCO2, pO2, hematocrit, and K+), and blood glucose levels over a 72 hour period for as many times as required, with results displayed on the dedicated bedside tablet.

All results are seamlessly transferred directly into the hospital laboratory information systems and electronic medical records (EMRs). Since the disposable sensor remains connected to the patient via their arterial line, a significant reduction in time to results is provided, when compared to conventional benchtop analyzers. This makes it particularly useful in the management of influenza, acute respiratory distress (ARDS), severe sepsis, trauma, traumatic brain injury (TBI), and other vulnerable conditions that require isolation in order to prevent contact and droplet-spread.

“Proxima is already redefining how arterial blood gas testing is carried out in critically ill patients, through its use for the close monitoring of patients in the UK, Germany, and Belgium,” said Wolfgang Rencken, CEO of Sphere Medical. “Based on clinical feedback, we have launched our next generation Proxima, which is now even better placed to support rapid and frequent measurements of blood gases, electrolytes and metabolites without blood loss. The addition of glucose to the analyte panel is the most significant new parameter, enabling better glycemic control in the critically ill.”

“The recent time and motion study we conducted at University Hospital Southampton clearly highlighted the workflow benefits of using Proxima on critically ill, unstable patients,” said professor of anesthesia and intensive care medicine Mike Grocott, MD, of the University of Southampton (United Kingdom). “We look forward to the launch of the new Proxima and the opportunity to use this device on a larger patient group within the ICU.”

Arterial blood gas analysis measures the blood gas tension values of arterial oxygen tension (PaO2), arterial carbon dioxide tension (PaCO2), acidity (pH), and arterial oxygen saturation (SaO2), among others. It is one of the most common tests performed in intensive care units and is intended to reflect gas exchanges across the alveolar-capillary membrane.

Related Links:
Sphere Medical


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.